Robinson v. McNEIL CONSUMER HEALTHCARE

671 F. Supp. 2d 975, 2009 U.S. Dist. LEXIS 106614, 2009 WL 3824669
CourtDistrict Court, N.D. Illinois
DecidedNovember 16, 2009
Docket07 C 5603
StatusPublished
Cited by2 cases

This text of 671 F. Supp. 2d 975 (Robinson v. McNEIL CONSUMER HEALTHCARE) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Robinson v. McNEIL CONSUMER HEALTHCARE, 671 F. Supp. 2d 975, 2009 U.S. Dist. LEXIS 106614, 2009 WL 3824669 (N.D. Ill. 2009).

Opinion

MEMORANDUM OPINION AND ORDER

JAMES F. HOLDERMAN, Chief Judge:

After a six-day jury trial in this pharmaceutical product liability ease, the jury reached a verdict, finding for plaintiff Karen Robinson on her negligence claim against defendant McNeil Consumer Healthcare (“McNeil”) but not on her identical claim against defendant Johnson & Johnson (collectively “Defendants”). The jury also found that Robinson was contributorily negligent and that her negligence proximately caused her injuries. Applying Virginia law, the court has determined that her contributory negligence completely barred her recovery against McNeil.

During trial, the parties filed timely motions for judgment as a matter of law under Federal Rule of Civil Procedure 50(a). After entry of the judgment on the jury’s verdict, Robinson filed her “Renewed Motion for Judgment as a Matter of Law, Motion to Amend the Judgment, and Motion for New Trial” [424], which is currently before the court. Defendants also filed their “Conditional Renewal of Rule 50(a) Motion for Judgment as Matter of Law Pursuant to Rule 50(b) After Trial” [422] in the event the court sets aside the jury’s verdict entered in their favor. For the reasons explained below, Robinson’s motion is denied, and, as a result, Defendants’ motion is denied as moot.

BACKGROUND

In the early hours of September 12, 2005, Karen Robinson awoke with a headache and decided to take her son’s Children’s Motrin to treat the pain. (Trial Tr. 540:18-541:1; 541:8-16; 541:25-542:21.) Although she had read the product’s warnings when she first purchased the product for her son about four or five months earlier, she did not review those warnings before taking the product on this occasion. (Id. at 596:10-14.) She took the dosage amount for a six to eight year old child— two teaspoons — and went back to bed. (Id. at 541:25-542:21.) When she awoke on September 12, 2005, she noticed some discoloration on her chest which continued to darken as the day progressed. (Id. at 549:17-21; 550:20-551:4.) During the middle of the second night she developed a fever and again decided to take two teaspoons of Children’s Motrin. (Id. at 551:19-552:14.)

The following day, September 13, 2005, Karen Robinson saw a doctor, Dr. Glenn Anderson, who prescribed a Medrol Pack to treat the apparent allergic reaction. (Id. at 553:14-17; 553:22-25; 554:14-18.) Although Robinson informed her doctor that she had taken Children’s Motrin, she did not discuss with him whether she should continue taking the medication. (Id. at 554:1-11.) Later that evening, the rash began forming blisters, and during the middle of the night, she noticed that her fever had increased. (Id. at 555:13-25; 556:16-21.) Robinson took the third and final, two teaspoon dose of Children’s Mot *979 rin around 2 or 3 o’clock in the morning on September 14, 2005. (Id. at 557:8-21; 558:1-4.) Because both her fever and rash were worsening despite having taken Medrol Pack, Robinson returned to her doctor in the morning on September 14, 2005. (Id. at 558:5-13.) She was hospitalized at the Fairfax, Virginia hospital and eventually transferred to the burn unit at Johns Hopkins in Maryland. (Id. at 560:5-8; 560:17-19.)

Robinson was diagnosed with toxic epidermal necrolysis (“TEN”), a severe form of Stevens-Johnson syndrome (“SJS”) that attacks an individual’s mucosal linings and results in severe internal and external burning. 1 (Id. at 77:13-78:14.) Robinson not only experienced significant skin sloughing but also blistering and burning throughout her body, including her mouth, eyes, throat, and internal systems. (See generally id. at 561:24-570:12 (testimony of Karen Robinson discussing extent of her injuries).) Due to the severity of her injuries, she was hospitalized for nearly a month. (Id. at 560:14-16.) Robinson ultimately lost the vision in her left eye and has limited vision in her right eye, which requires constant medical treatment. (Id. at 568:18-569:14.)

Karen and Jonathon Robinson originally filed this lawsuit in Illinois state court against McNeil, the manufacturer of Children’s Motrin, and Johnson & Johnson, McNeil’s parent corporation, alleging that Karen Robinson suffered physical injuries resulting from her ingestion of Children’s Motrin in September 2005. Defendants removed this lawsuit to federal court based on diversity jurisdiction in October 2007.

Before trial, the court determined that Virginia law applied to the Robinson’s claims, thereby barring Jonathon Robinson’s sole claim for loss of consortium and Karen Robinson’s strict liability claims. (Dkt. No. 306.) The court additionally found that any punitive damages would be capped at $350,000 as required by Virginia law. (Id.) Because Robinson expressly waived her implied warranty claims in the parties’ Final Proposed Pretrial Order without respect to whether Illinois or Virginia law governed (see Dkt. No. 245), the court also precluded Robinson from pursuing that theory of liability at trial (see Dkt. No. 400).

The case proceeded to trial on Robinson’s two negligence theories against McNeil and Johnson & Johnson: (1) the Children’s Motrin was defectively designed, and (2) the Children’s Motrin’s warnings were inadequate. Defendants denied that they were negligent and further asserted that notwithstanding any alleged negligence, Karen Robinson’s own contributory negligence barred her recovery.

After the six-day trial, the jury returned a verdict finding that defendant McNeil, but not defendant Johnson & Johnson, was negligent and that its negligence proximately caused Karen Robinson’s injuries. The jury also found that Robinson was contributorily negligent. Under Virginia law, Robinson’s contributory negligence is a complete bar to recovery. Litchford v. Hancock, 232 Va. 496, 352 S.E.2d 335, 337 (1987) (“[A]ny negligence of a plaintiff which is a proximate cause of the accident will bar a recovery.”).

During the trial, at the conclusion of the evidence, the parties filed timely motions for judgment as a matter of law under Federal Rule of Civil Procedure 50(a). Currently before the court is Robinson’s *980 “Renewed Motion for Judgment as a Matter of Law, Motion to Amend the Judgment, and Motion for New Trial” [424], and Defendants’ “Conditional Renewal of Rule 50(a) Motion for Judgment as Matter of Law Pursuant to Rule 50(b) After Trial” [422], For the reasons explained below, Robinson’s motion is denied, and, as a result, Defendants’ motion is denied as moot.

ANALYSIS

1. Judgment as a Matter of Law

As a federal court exercising diversity jurisdiction under 28 U.S.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Goldman v. Kattouah (In Re Kattouah)
452 B.R. 604 (E.D. Michigan, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
671 F. Supp. 2d 975, 2009 U.S. Dist. LEXIS 106614, 2009 WL 3824669, Counsel Stack Legal Research, https://law.counselstack.com/opinion/robinson-v-mcneil-consumer-healthcare-ilnd-2009.